Nabsys Launches Tool to Analyze Genetic Repeat Expansions Linked to Inherited Disorders
New software allows researchers to examine repeat expansions associated with up to 23 disease-related genetic regions in a single run.
Read MorePosted by CLP Edit Staff | Oct 16, 2026 | Analytical Software Systems, Company News, Molecular Diagnostics |
New software allows researchers to examine repeat expansions associated with up to 23 disease-related genetic regions in a single run.
Read MorePosted by CLP Edit Staff | Oct 9, 2026 | Infectious Diseases, Urinalysis & Toxicology |
A multicenter study from Johns Hopkins Medicine found that an FDA-cleared rapid urine assay detected 92% of invasive aspergillosis cases, offering results within hours and supporting faster, noninvasive diagnosis in clinical labs.
Read MorePosted by CLP Edit Staff | Oct 7, 2026 | Cancer, Leukemia, Molecular Diagnostics |
10x Genomics and Fred Hutchinson Cancer Center have launched a multi-project collaboration to study single cell and spatial profiling for cancer diagnostics, including biomarkers in bladder cancer and residual disease detection in AML.
Read MorePosted by CLP Edit Staff | Oct 6, 2026 | Cancer, Molecular Diagnostics |
Pillar Biosciences has introduced the oncoReveal Myeloid v2 Panel, expanding its NGS assay from 58 to 80 genes and enhancing FLT3-ITD detection while maintaining existing laboratory workflows.
Read MorePosted by CLP Edit Staff | Sep 24, 2026 | Lab Automation |
OGT has launched automation-enabled SureSeq NGS workflows compatible with the Hamilton NGS STAR Line, aiming to reduce manual steps and increase throughput for clinical research labs managing higher sample volumes.
Read More